Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-021149
Filing Date
2022-05-31
Accepted
2022-05-31 07:31:45
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10038332_defa14a.htm DEFA14A 47407
2 EXHIBIT 10.1 brhc10038332_ex10-1.htm EX-10.1 113475
3 EXHIBIT 10.2 brhc10038332_ex10-2.htm EX-10.2 41054
4 EXHIBIT 99.1 brhc10038332_ex99-1.htm EX-99.1 12748
5 image00001.jpg GRAPHIC 6113
6 image00002.jpg GRAPHIC 5783
  Complete submission text file 0001140361-22-021149.txt   232612
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11460 | Film No.: 22980480
SIC: 2834 Pharmaceutical Preparations